The development of pharmaceutical and biomedical sciences today is progressing rapidly, particularly in the fields of translational medicine and personalized therapy. These approaches require the integration of molecular research, bioinformatics, artificial intelligence, and pharmacogenetics to optimize therapies based on the individual characteristics of each patient. In this context, international collaboration